Abstract
Introduction:
HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) shows distinct biological and clinical behaviour when compared to HPV-negative OPSCC. The overall role of the tumour microenvironment (TME) in head and neck cancer progression and metastasis has been studied intensively, but differences in HPV-negative and HPV-positive OPSCCs are less understood.
Objective:
To investigate the role of cancer-associated fibroblasts (CAFs) and the functional interactions of normal tonsil fibroblasts (NTFs) and OP CAFs with HPV+ and HPV− OPSCC cells and explore novel candidates in tumour-fibroblast crosstalk.
Materials and methods:
A retrospective cohort of 143 primary OPSCCs was characterised using HPV16/18 RNAScope assay, p16 IHC and ɑ-SMA. Four OPSCC, three NTF and 2 new OPSCC CAF cultures were used to assess the cytokine-based interactions using cytokine arrays on conditioned media (CM), followed by co-culture approaches to identify the role of individual cell types and the role of OPN (SPP1) and IL-6 in SCC/fibroblast communication.
Results:
HPV status was associated with better overall survival. Although ɑ-SMA expression was observed in both OPSCC subtypes, it provided survival stratification only in the HPV−positive group (Log-Rank p = 0.02). Three normal tonsillar fibroblast cultures (NTFs) were characterised by induction of myofibroblastic and senescent phenotypes with similar reactivity to our published NOF phenotype. The OPSCC-derived CAF cultures were characterised and their baseline myofibroblastic and senescence phenotypes varied. Cytokine array analysis of CM to identify novel candidates in the crosstalk between OPSCC tumour cells and NTFs/CAFs identified differences in the cytokine profiles on comparison of HPV+ and HPV− OPSCC cells. Osteopontin (OPN/SPP1) was identified, particularly in HPV-negative OPSCC cell analyses. We have demonstrated that OPN was produced by the OPSCC cells and revealed an associated upregulation of IL-6 in fibroblasts. Treatment of NTFs with rOPN showed alteration in phenotype, including increased contraction and IL-6 production. Antibody-mediated inhibition of CD44v6 attenuated the production of IL-6 by OPN in NTFs.
Conclusion:
This investigation with OPSCC fibroblasts provides novel insights into the role of CAFs in OPSCC mediated by IL-6 stimulated release of OPN from HPV negative OPSCC cells. The details of HPV-positive SCC cell/fibroblast cytokine crosstalk remain elusive.
Introduction
The past few decades have seen a marked increase in squamous cell carcinomas (SCCs) of the oropharynx. In the UK, this has included increases in the incidence of both HPV-associated SCC and conventional SCC (1, 2). These subtypes bring differing clinical and molecular features with associated differences in survival (3). Given the superior prognosis of HPV-driven OPSCC there is wide interest in treatment de-intensification programmes, but initial results of these clinical trials have been disappointing (4, 5). In this context, it is an interesting question if patient selection based on HPV-status alone is too simplistic and may require a deeper understanding of the biology of both the epithelial component and the tumour microenvironment (TME) to support more appropriate selection of patients for such de-intensification approaches.
The tumour microenvironment comprises a rich community of cellular and non-cellular components which have been shown to play a key role in the development and progression of many malignant neoplasms (6). In oral cavity SCC, the presence of an extensive, activated myofibroblast population in the TME (as measured by αSMA expression), is a better predictor of poor clinical outcomes than many of the traditional clinical staging tools (7).
Fibroblasts in the TME of solid tumours, frequently termed cancer associated fibroblasts (CAFs) are a variably prominent component which exert profound influences on tumour behaviour. CAFs have shown the capability to enhance tumour growth, local invasion, and metastasis (8, 9) and are correlated with poor clinical outcome in several tumours (10–13). Single cell sequencing of the TME in HNSCC has confirmed that CAFs are not a homogeneous group; several sub-populations have been identified, some of which have been associated with poor prognosis, whilst others with a more favourable prognosis (14, 15). Even in those fibroblasts which express high levels of αSMA, there is significant heterogeneity, as these may by induced by several stimuli, including TGF-β1 and cellular senescence (16).
Although well-established for OSCC, the role that the CAFs play in OPSCC has been less thoroughly investigated. Recent RNASeq analysis of a cohort of OPSCCs indicated that the TME in HPV-positive and negative OPSCC was differentially enriched: HPV-negative dominated by fibroblasts and capillary endothelial cells, whereas the HPV-OPSCC TME was enriched for adaptive immune cells (17), suggesting fundamental differences in the TME exist. Similar differences in the fibroblast content have also been noted on multiplex image cytometry (18).
We have previously reported differences in the interaction of HPV-positive and HPV-negative OPSCC cell lines with fibroblasts in various 2D and 3D models (19). HPV-negative cell lines were able to stimulate normal oral fibroblasts to produce a secretome which enhanced cancer cell migration and invasion, whilst HPV-positive cells did not, this at least in part due to the action of HGF. These interesting observations highlight the need for further investigation and clinical validation of fibroblast function in OPSCC model systems and in tissues. In this study we extend our investigation of the fibroblast component of the TME in OPSCC, focussing on its relation to clinical outcomes and how epithelial cell HPV-status is related to the interactions of tonsil-derived fibroblasts and OPSCC cells.
Methods
Cell lines and culture conditions
OPSCC cell lines UD SCC02, UPCI SCC072, UPCI SCC089 and UPCI SCC090 were used in this project: the UPCI cell lines were received under MTA from Prof. S. Gollin, University of Pittsburgh School of Public Health, Pittsburgh, PA. The HPV status was confirmed as previously described (19). Short tandem repeat profiling was undertaken to confirm cell line authenticity. A summary of cell lines used is given in Supplementary Table S1.
Fibroblast cultures were derived from normal tonsil and OPSCC explant cultures respectively, (NTF06, NTF10, NTF322, CAF1, CAF2) as described previously (20), using tissue retrieved from patients during ENT surgery, with written, informed consent, under ethical approval (09/H1308/66 and 13/NS/0120: Supplementary Table S2). The authors are grateful to Dr Helen Colley for access to the NTF cultures). Both fibroblasts and OPSCC cell lines were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal calf serum, with 2 mM L-glutamine and 50 IU penicillin and 50 μg ml−1 streptomycin and incubated under standard conditions (5% CO2, 37°C). All cell cultures were subject to regular mycoplasma testing.
CAF growth rates
CAF1 and CAF2 were seeded at a density of 5,000 cell/ml in a 6 well-plate with 2 ml growth media for 6 days. At daily intervals, cells from one well of the 6 well-plates were detached and counted giving the total count/ml of cells.
Fibroblast culture treatments
TGF-β1: Cells were plated into 6-well plates (Greiner Bio-one, UK) at a density of 1.5 × 105 per well with 2 ml of growth media and incubated overnight at 37°C. The next day, the media was aspirated, and cells were washed with PBS x2 and serum-starved overnight using DMEM serum-free media. On the third day, 2 ml of DMEM serum-free medium containing 5 ng/ml rh-TGF-β1 (Sigma-Aldrich, UK) was added to each well. The experimental control wells were incubated with 1 ml serum-free medium. Cells were incubated with 5 ng/ml TGF-β1 (R&D Systems, USA) for 24, 48 or 72 h. At the end of the experiment, cells were pelleted for downstream RNA/protein analysis and the media was aspirated, centrifuged, and the supernatant was stored at −20 °C.
H2O2: Early-passage NTF322, NTF6 and NTF10 cells were grown in 75 cm2 flasks to 70% confluence. Cells were then washed with PBS and incubated with 500 µM of H2O2 (Sigma-Aldrich, UK) in serum-free media for 2 h. Negative control cells were incubated with serum-free media alone. Cells were then washed with PBS x3 and incubated with growth media for 15 days. Cells were split on day 8. At the end of the experiment, the media were collected, centrifuged at 3,000 rpm for 5 min and stored at −20 °C. Cells were counted and the culture viability percentage was recorded. 4 × 104 cells were seeded in a 12-well plate, prepared for Senescence-Associated β-galactosidase Assay (SA-β-gal) staining. The rest of the suspension was centrifuged, and the formed pellet was collected and stored at −80 °C for further analysis.
Recombinant Osteopontin (rOPN): Fibroblasts were cultured in a T75 cm2 flask in growth media to 70% confluence. Cells were washed with PBS x3 and serum-starved overnight. On the third day, cells were incubated with 10 ml of serum-free medium containing 180 ng/ml of rh-OPN (R&D systems, USA) for 48 h. The experimental control was incubated with 10 ml serum-free media only. At the end of the experiment, the media were aspirated, centrifuged, and stored at −20 °C for IL-6 ELISA analysis. Cells were harvested and counted to normalise ELISA analysis results then cells were collected for further IL-6 gene evaluation.
Anti-CD44v6 antibody: NTF322 and NTF10 were cultured in T75 cm2 flask with growth media up to 70% confluence. Cells were incubated for 1 h with serum-free media supplemented with 5 µg/ml of CD44var (v6) Monoclonal Antibody (VFF-18) (eBioscience™ Catalogue: BMS125). The experimental control was incubated with serum-free media. 6.5 ml of cell line conditioned media from SCC89, SCC72 and SCC2 was thawed and supplemented with 1.5 ml of fresh growth media. After 1 h of CD44 blocking, rOPN-containing or control CM was added to NTFs and incubated for 24 h. The next day, media were collected, centrifuged, and stored at −20 °C. Fibroblasts were harvested, counted, and collected as a cell pellet for further analysis.
Collagen gel contraction assay
Following the protocol of the collagen gel contraction kit (Cell Bio-Lab Inc, CBA-201), NTFs were harvested and resuspended in growth medium at 2 × 104 cells/ml. A collagen lattice was prepared by mixing 2 parts of cell suspension and 8 parts of cold collagen gel working solution. From this mixture, 0.5 ml was pipetted in a well in a 24-well plate and incubated for an hour at 37 °C. After collagen polymerization, 1 ml of growth medium was added, and the plate incubated for 24 h at 37 °C. The next day, the cells were serum-starved for a further 24 h, then were treated with 5 ng/ml TGF-β1 or 180 ng/ml OPN before releasing the stressed gel matrix from the plate using a sterile spatula. The gels were then incubated for 72 h (TGF-β1 stimulation experiment) or 48 h (rOPN stimulation experiment). Photographs of the gel disc were taken at 24, 48 and 72 h. The contractility of the gels was calculated by measuring the distance between the collage disc border and the plate well using ImageJ (NIH).
Collection of conditioned media
Cell lines were grown to 70% confluence in T75 flasks, washed in PBS and incubated with fresh normal media for 24 h. Conditioned medium (CM) was then retrieved, centrifuged at 3,000 rpm for 5 min to remove cell debris and stored at −20 °C. The remaining cells were counted, and CM normalized to a concentration of 3 × 106 cells/ml.
Tonsil fibroblast cultures (normal and CAF) were grown to confluence in T75 flasks, washed in PBS and incubated with either OPSCC cell line CM or normal media control for 24 h. This media was collected (M1) and flasks were washed in PBS and incubated with fresh normal media for a further 24 h to collect a “stimulated” fibroblast CM (M2). CM was retrieved, centrifuged at 3,000 rpm for 5 min and stored at −20 °C. The remaining cells were counted to confirm an equal number of cells in each experiment post-stimulation.
OPSCC cell lines were exposed to unstimulated fibroblast CM collected in a similar manner to that described above.
Transwell co-culture
Cancer cells (3 × 105) were seeded in 1.5 ml of growth media on cell culture inserts containing a 0.45 μm plastic membrane filter and placed on a 6-well plate filled with 2.6 ml of growth media. Cells were allowed to adhere overnight. The filters were conditioned before cell seeding to enhance the cellular adhesion by preincubation for a minimum of 1 h at 37 °C. 50,000 cells of NTF 3, NTF 10, CAF1 or CAF2 were plated in 6-well plate in 2 ml growth media and incubated for 24 h The experimental controls were plated in the same way but omitting the fibroblasts or cancer cells. The next day, 1.5 ml fresh growth media was added to the inserts and 2.6 fresh growth media was added to the fibroblasts in 6-well plate, then the cell culture inserts were inserted into the wells carefully to avoid air bubble formation. The co-culture system was maintained for 48 h at 37 °C. At the end of the experiment, the media were aspirated and centrifuged at 3,000 rpm for 5 min and stored immediately at −20 °C. Cancer cells and fibroblasts were detached from the culture system, counted, and stored separately as pellets at −80 °C.
Cytokine array
Serum-free conditioned media were collected from cell lines and stimulated fibroblasts as described above and soluble factors analysed by cytokine array Proteome Profiler Human XL Oncology Array kit (R&D systems: ARY026) following the manufacturer's protocol. This kit provides relative expression levels for 84 human cancer-related proteins. Developed films were scanned at high resolution and analysed using ImageJ Studio software (Version 5.2; LI-COR, Inc, USA). Densitometry data were then normalised to the positive control spot (reference spots).
qPCR
Total RNA was extracted from cell pellets using an Isolate II RNA Mini Kit (Bioline), following the manufacturer's instructions. RNA was quantified using a Nanodrop 1,000 Spectrophotometer (Thermo Fisher Scientific). Five hundred nanograms of isolated RNA was reverse transcribed using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems), following the manufacturer's protocol using a Peltier thermal cycler (MJ Research). cDNA was then stored at −20 °C.
Gene expression was quantified using a Rotor-gene Q real-time PCR cycler (Qiagen) with SYBR green or TaqMan chemistry. Quantification was achieved using delta CT values normalized to either U6 or B2M. Each reaction was performed in triplicate. The standard thermal cycle settings for a reaction consisted of 40 cycles (each 95 °C for 10 s, 60 °C for 15 s and 72 °C for 20 s), including a melt curve analysis (when using SYBR green).
Taqman (inventoried, Thermo Fisher Scientific, UK) and SYBR green primers (designed in-house, purchased from Sigma-Aldrich) were used, as seen in Supplementary Table S3.
Western blot
Cell lines were grown to approximately 70% confluence, washed in PBS. On completion of each respective incubation period (as above), flasks were washed in cold TBS and detached using cell dissociation solution at 4 °C on a rocking machine for 10 min. Cells were centrifuged at 1,000 rpm for 5 min. Cell pellets were lysed on ice in 50 mM Tris–HCL pH 7.4, 250 mM NaCl, 5 mM EDTA, 0.3% Triton X-100 and EDTA-free protease inhibitor cocktail (Roche, Germany).
Lysates were boiled for 5 min in an equal volume of sample buffer and separated using 4%–15% polyacrylamide pre-cast gels (Mini-Protean TGX, Bio-Rad, CA). Separated samples were transferred to a nitrocellulose membrane (Amersham Hybond ECL, GE Healthcare, Chicago), then blocked in 5% skimmed milk in Tris-buffered saline (pH 7.4) with 0.1% Tween-20. This was followed by incubation with primary antibody (Supplementary Table S4) or anti-β actin control (1:3,000) in 5% bovine serum albumin/TBST overnight at 4 °C. Membranes were then incubated with horseradish peroxidase conjugated secondary antibody at a dilution of 1:10,000 for 45 min and imaged using ECL reagent (GE Healthcare).
Immunofluorescence
An 8-well slide chamber (Starstedt, GER) was used to culture the cells for immunofluorescence analysis. 20,000 cells were seeded in each chamber with 800 μl of growth media. Chambers were incubated for 24 h at 37 °C in a humidified incubator with 5% CO2. After treatment with TGF-β1 or OPN, cells were fixed using the recommended reagent according to the manufacturer's instructions This was followed by another incubation with the permeabilization reagent if needed. After that, cells were blocked by the appropriate blocking on a shaker for 15 mins. 200 μl of the diluted primary antibody was added, including the experiment negative control, and incubated for 1.5 h (Supplementary Table S4). Cells were then washed twice with PBS and incubated with the secondary antibody for 1 h. The antibody control chamber was incubated with 200 μl of secondary antibody only. The chambers were washed x3 with PBS and mounted with a coverslip containing a drop of Prolong diamond antifade mountant (DAPI, Thermo Fisher P36966). The slide was placed in a slide box at 4 °C for 24 h. Images were captured using a Ziess Axioplan2 fluorescence light microscope (Carl Zeiss, UK). Staining intensity was quantified using Image J software quantifying the green colour only in fields with equal numbers of cells.
IL-6 ELISA
Secreted IL-6 was quantified using the BD OptEIA (BD Biosciences, San Jose, USA) kit for human IL-6 detection. The procedure was performed following the manufacturer's recommendation using 96-well plates. Absorbance was read at 450 nm within 30 min of adding the stop solution. Wavelength correction was calculated by subtracting the absorbance at 570 nm from the absorbance at 450 nm.
Senescence associated β-galactosidase staining
Twenty thousand cells per well were seeded in a 12-well plate and left to adhere overnight. Senescence associated β-galactosidase activity was assessed using a senescence detection kit (ab65351, Abcam) following the manufacturer's recommendations.
Tissue microarray (TMA) cohort and construction
This study utilised patient samples and associated clinical data within the period of primary diagnosis 2002–2012. Patients were selected using the Oncology databases and cross-referenced against the histopathology archive at Sheffield Teaching Hospitals NHS Trust. Patients were included in the study if there was sufficient tissue remaining after diagnosis for TMA generation and if there was a reasonably complete dataset of associated clinicopathological information. All biopsy material was obtained before commencement of anti-cancer treatment. Paraffin-wax embedded tissue samples were retrieved and collated in a blinded fashion with respect to HPV status. Clinical data regarding tumour recurrence, clinical status and overall survival were retrieved from the patient's medical files at the Sheffield Teaching Hospital NHS Foundation Trust, UK. Overall survival was determined by the difference between the date of treatment and either the date of death due to the tumour or last follow-up. The study was conducted with National Research Ethical Committee approval (UK 12/LO/2018).
TMAs were constructed by selecting tumour regions displaying more than 70% cellularity with minimal necrosis and marked on haematoxylin and eosin-stained sections. The TMAs were constructed using a Beecher tissue arrayer with 3 × 1.0 mm diameter cores from each tissue block arranged at mapped locations into recipient paraffin blocks. TMAs were sectioned (5 μm) by microtome onto Superfrost™ adhesive glass slides (ThermoFisher Scientific).
An additional cohort of 96 cases was added, which had formed part of the PREDICTR study cohort (21). These were received from the University of Birmingham under MTA. An overall summary of the whole cohort is presented in Table 1.
Table 1
| HPV- positive | HPV- negative | Total | p-value | |
|---|---|---|---|---|
| Number of cases | 87 | 56 | 143 | - |
| Age at diagnosis | ||||
| <45 | 9 | 6 | 15 | 0.71 |
| 45–55 | 31 | 15 | 46 | |
| 56–65 | 33 | 24 | 57 | |
| >65 | 14 | 11 | 25 | |
| Mean | 56.1 | 56.9 | 0.91 | |
| Median | 55 | 57.5 | ||
| Sex | ||||
| Male | 65 | 39 | 104 | 0.65 |
| Female | 22 | 17 | 39 | |
| Smokinga | ||||
| Never | 38 | 7 | 45 | <0.001 |
| Former | 20 | 15 | 35 | |
| Current | 20 | 29 | 49 | |
| T-stage | ||||
| T1/T2 | 56 | 28 | 84 | 0.07 |
| T3/T4 | 31 | 28 | 59 | |
| N-stage | ||||
| N0/N2a | 30 | 17 | 47 | 0.07 |
| N2b/N3 | 57 | 39 | 96 | |
| TNM staging | ||||
| III | 30 | 30 | 60 | 0.02 |
| IV | 57 | 26 | 83 | |
| Treatment | ||||
| Surgery | 31 | 38 | 69 | <0.001 |
| Chemo-radiotherapy/ Radiotherapy | 56 | 18 | 74 | |
| Recurrence | ||||
| Yes | 9 | 14 | 23 | 0.03 |
| No | 78 | 42 | 120 | |
| Survival | 0.002 | |||
| Alive | 14 | 21 | 35 | |
| Dead | 73 | 35 | 108 | |
OPSCC clinical cohort details. Regarding treatment, all patients were treated with curative intent, and the treatment noted in the primary modality. Some patients underwent multi-modality treatment.
Note that for smoking status, this data is incomplete.
Immunohistochemistry
Immunohistochemistry for p16 and
αSMA was performed on 4 µm formalin-fixed paraffin-embedded TMA sections. Human skin sections were used as positive controls. Antigen retrieval was performed with heat-induced epitope retrieval in sodium citrate buffer (10 mM sodium citrate, 0.05% Tween 20, pH 6.0). The primary antibody used are noted in
Supplementary Table S4, and samples were incubated overnight at 4 °C. After secondary antibody incubation, staining was visualized using a Vectastain ABC Kit (Vector Laboratories) with 3,3′-diaminobenzidine substrate and a haematoxylin counterstain. Staining was assessed as follows:
- •
p16 (E6H4 CINTECH, using standard diagnostic p16 protocol). Expression was assessed semi-quantitatively, using H-score, to a maximum score of 300. Staining intensity (0–3) and % of cells at each stating level is recorded.
- •
αSMA (1:100). Staining was assessed as “high” or “low” using published assessment criteria (21). In general, low cases had focal <50% of stroma expressing αSMA, whilst high is >50%.
RNAScope ISH
HR-HPV16, 18 E6 and E7 RNA ISH was performed with the RNAscope assay (Advanced Cell Diagnostics, Newark, CA, USA), according to the manufacturer's instructions. The following scoring system was followed for HPV RNA ISH slide assessment: 0: No staining or <1 dot every 10 cells; ×40 magnification. 1: 1–3 dots/cell; ×20–×40 magnification. 2: 4–10 dots/cell; very few dot clusters at ×20–×40 magnification. 3: >10 dots/cell; <10% have dot clusters at ×20 magnification. 4: >10 dots/cell; >10% positive cells have dot clusters at ×20 magnification. Score 0 was counted as a negative result and scores 1–4 as positive.
Statistical analysis
All experimental data are expressed as mean ± SD of at least three independent experiments performed in triplicate, unless otherwise stated. Data are expressed as mean ± standard error (unless stated). A p-value of <0.05 was considered to be statistically significant.
Ethical considerations
The study was approved after ethical reviews: 09/H1308/66 (generation of NOFs) and 13/NS/0120 (generation of CAFs) and 12/Lo/2018 (patient cohort). All the clinical cases were pseudo-anonymised before analysis.
Results
HPV status is linked to overall survival, but αSMA expression is only linked to overall survival in HPV-positive cases
The demographic details of the clinical cohort are presented in Table 1. Assessment of HPV status in the clinical cohort (n = 143) by both p16 IHC and HPV 16/18 RNA ISH demonstrated poorer overall survival related to the expression/presence of either biomarker (Figure 1A: p16 p = 0.0002, HPV ISH p < 0.001). In the assessment of αSMA expression (assessed as low or high: see Figures 1B1,B2), high αSMA expression was related to survival in only in HPV-positive cases (Figure 1B: HPV+ p = 0.02, HPV− p = 0.77).
Figure 1
Normal tonsil fibroblasts respond to treatment with TGFβ and H2O2 in a very similar manner that that previously described in oral normal fibroblasts
We previously published a comprehensive characterisation of normal oral fibroblasts (NOF) in a overall similar experimental protocol (19), but it is possible that anatomical variations in mesenchyme may result in differences in fibroblast reactivity. Thus, we undertook characterisation of 3 new normal tonsil fibroblast (NTF322, NTF6 and NTF10) cultures, which allowed comparison with NOF cultures. We have demonstrated that all the NTF cultures respond to treatment with TGFβ1, with maximal effect seem at 48 h at transcript level (Figure 2A1), and 48–72 h at protein level (Figure 2A2). The development of αSMA stress fibres mirrored these changes (Figure 2A3). The functional consequences of this are seem in the increase in collagen gel contraction under the same treatment and timescale (Figure 2B), and in an increase in the production of IL-6, at protein level, but this was variable between the cultures and timepoints, with no increase noted in NTF322 (Figure 2C).
Figure 2
Treatment with H2O2 resulted in a significant increase in the percentage of SA-β-Galactosidase activity (widely used as an indicator of senescence) in all cultures (Figure 3A), with associated increases in the expression of p16 and p21 in NTF332 and NTF6, assessed by western blot (Figure 3B). H2O2 treatment also resulted in an increase in the production of IL-6 in NTF6 and NTF10 (Figure 3C).
Figure 3
These results are very similar to those previously demonstrated using NOFs and a similar treatment schedule, with the induction of aSMA stress fibres on treatment with TGFβ1, and the induction of SA-β-Galactosidase activity on treatment with H2O2 (16).
Characterisation of tonsil CAF cultures demonstrates differential baseline levels of senescence and reactivity to TGFβ
A similar process of characterisation for the two new tonsil CAF cultures (CAF1 and CAF2) was undertaken, after confirmation of lack of contamination of these cultures by other cell types. qPCR assessment of cytokeratin 6, HLA-DR and CD31 demonstrated no significant expression in the cultures, indicating lack of epithelial, lymphocyte and endothelial cell contamination (Supplementary Figure S1). The two CAF cultures, which were both derived from HPV-positive tumours in patients who were both current smokers varied in their phenotype (Figure 4). Whilst both CAF1 and CAF2 increased their expression of αSMA (mRNA transcript and stress fibre formation; Figure 3A), the baseline expression of αSMA was higher in CAF2 than in CAF1. We also identified higher expression of FAP-α and FSP1 in the CAFs when compared to NTF6 (Figure 4B), and similar patterns of expression of PDGRA (data not shown). On assessment of the proportion of senescent cells at baseline, there was a higher proportion of senescent cells in CAF1 cultures (Figure 4C). Treatment of CAF1 and CAF2 with H2O2 resulted in an increase in the proportion of SA-β-Gal expressing cells, with the dynamic change greater in CAF2 (Supplementary Figure S2).
Figure 4
The assessment of growth curves, with NTF6 for comparison, also demonstrated differences between CAF1 and CAF2, with the rate of increase in cell numbers less in CAF1, likely due to the higher proportion of senescent cells in these cultures (Figure 4D). Notably, both CAF cultures produced a much higher baseline level of IL-6 production when compared to NTF6, in keeping with the higher baseline SA-β-Gal and αSMA expression (Figure 4E).
Culture of tonsil fibroblasts with conditioned media from OPSCC cultures results in differential cytokine expression when comparing media from HPV-positive and HPV-negative cells
In our previous OPSCC paper, we demonstrated the baseline cytokine production of the OPSCC cells (19). The current assessment, which includes a small number of additional cytokines not assessed previously, was undertaken on untreated CAF1, CAF2 and NTF322 cultures (Supplementary Figure S3). This demonstrated a limited baseline repertoire of chemokine production: In CAF1 and CAF2, only CCL2 and MMP2 were detected (with weak expression of SPARC in CAF2), whilst SPARC, Serpin B5 and DCN were detected in NTF322 conditioned media.
After 24 h of treatment of the fibroblast cultures with OPSCC CM, two different collections of conditioned media were made: firstly, the initial 24 h CM, which contains cytokines from both the SCC cells and fibroblasts, and after washing and incubation for a further 24 h in fresh media, the second CM was collected (fibroblast produced cytokines only). The initial conditioned media (CM1) was subjected to cytokine array analysis as shown in Figures 5A–F. The chemokines which were detected are presented in Supplementary Table S5. Several cytokines were detected in the CM which was originally derived from HPV+ and HPV− cells, some of which were also detected in the baseline fibroblast media (Supplementary Figure S3), including CCL2. Increased production was detected solely related to HPV+ cell CM. The cytokine profiles are much reduced in the later CM2 (Supplementary Figure S4), but with a notably increased repertoire still evident in fibroblast CM which has been stimulated by HPV− SCC CM, when compared to HPV+.
Figure 5
We identified OPN (SPP1) as a consistently produced cytokine present in the CM1 from all fibroblast cultures in response to SCC89 CM (HPV negative). Validation of the findings from the cytokine array by ELISA in CM1 demonstrated similar findings (Figure 5H), but OPN is not detected in CM2 (Supplementary Figure S4), which indicates that the source is not the fibroblast cells. qPCR assessment of the OPSCC cells indicated variable baseline transcription of SPP1, higher in HPV-negative cells (SCC 72, SCC89) than in HPV positive (SCC2, SCC90) cells (Figure 5J). We also validated the production of CCL2 in CM1 by ELISA, with no difference in SCC89 and SCC2 CCL2 production in response to CAF1 and CAF2 CM, but variable when stimulated by NTF media (data not shown).
Transwell co-culture methods identify SCC cells as the primary source of osteopontin and fibroblasts as the source of IL-6
We used a transwell co-culture method to allow the cells to communicate in a paracrine manner but with no direct contact, allowing for separate transcript analysis of the different cells used. Assessment of OPN transcript levels by qPCR indicated that these were only elevated in the HPV-negative cells when co-cultured with either CAFs or NTFs (Figure 6A). No expression was seen either in HPV-positive SCC cells or in CAFs or NTFs. Conversely, IL-6 transcript was increased only in CAFs and NTFs when cultured with conditioned media from HPV-negative SCCs (Figure 6B). no increase was seen in the OPSCC cells of in CAFs/NTFs cultured with HPV-positive SCC conditioned media.
Figure 6
Treatment of tonsil fibroblasts with recombinant osteopontin results in increased contraction and IL-6 production which can be inhibited by receptor blocking antibodies
Having established that OPN was being produced by the HPV-negative SCC cells in response to fibroblasts, we treated CAF2 and NTF cultures with recombinant OPN (rOPN). This resulted in increased contraction of collagen gels for NTF10 and CAF2, with increased production of IL-6 (transcript and protein) also detected (Figures 7A,B). The increase in IL-6 production could be reduced, but not abolished, by pre-treatment with anti-CD44V6 antibody (Figure 7C), in keeping with data which demonstrates OPN binding to proteins other than its specific receptor, such as multiple integrins (22). Pre-treatment of fibroblasts with anti-CD44V6 before culture with OPSCC conditioned media showed a reduction in IL-6 production in fibroblasts which were treated with HPV-negative SCC CM, whilst no significant difference was noted in fibroblasts which had been cultured in HPV-positive SCC CM (Figure 7D).
Figure 7
Discussion
The role of fibroblasts in the tumour microenvironment of OPSCC has been understudied, even when compared to those at other sites within the head and neck. Others have shown that CAFs are frequently identified in the TME of HPV+ OPSCC (23), but, in general, the data (IHC and sequencing) suggests higher fibroblast signatures in HPV-negative OPSCC when compared with HPV-positive OPSCC (18). The data which we have generated from the assessment of the OPSCC TMAs would bear this out (Figure 1). Other investigators have demonstrated that stromal desmoplasia (by morphological assessment alone or by αSMA expression) is associated with poorer disease specific survival in both HPV+ and HPV-negative (24), whereas we only found this relationship in HPV-positive tumours (Figure 1).
Expression of various CAF markers in OPSCC has been investigated by others who have reported the involvement of members of the Fibroblast Growth Factor Receptor family: FGFR1 has been reported as more highly expressed in HPV-negative OPSCC, but not related to outcome (25): FGFR3 expression correlates with mutant p53 expression and poor survival in p16-negative OPSCC (26): FGFR4 expression has been described in OSCC and OPSCC, without any link to survival (27). Other stromal fibroblast associated markers, such as PDGFR-a, may be activating mesenchymal stem cell in the HNSCC TME to form CAFs (28). In the limited studies available, most demonstrate both qualitative and quantitative differences between the TME of HPV-positive and HPV-negative tumours.
In this study, we have expanded on our earlier work characterising the interaction between normal oral fibroblasts and OPSCC cells (19). The earlier investigations highlighted the importance of IL-6 in cytokine-mediated communication between NOFs and OPSCC cells, and our initial aims were to determine if tonsil-derived fibroblasts, both normal (Figures 2, 3) and cancer-derived (Figure 4) would behave in a similar manner. We have now demonstrated that NOFs and NTFs respond similarly to each other in terms of phenotypic changes on stimulation with TGF-β1 and H2O2 [Figure 2, compare with (19]), but also in their interactions with OPSCC cells (Figure 4). Similar features have been demonstrated in the interaction of cervical cancer cells and cervix CAFs in culture (29).
In this study, we also report the characterisation of two CAF cultures derived from OPSCCs (Figure 4). These fibroblast cultures vary in their basal expression of αSMA and SA-β-Gal activity (as a surrogate marker of senescence), but both can interact with the HPV-negative OPSCC cells in a similar manner (Figure 5). This, however, does raise an interesting issue: that CAFs vary in phenotype is now very evident from single cell sequencing analyses (14, 30) and that these are related to various roles in the TME, including immune infiltration. However, the question of whether all the described CAF phenotypes result in distinct functional states still requires to be addressed in detail. In this context, we have demonstrated that OPN is another partner in IL-6 driven communication between cells in the TME, which impinges on many of these varied CAF functions. A further point to note is the age difference between the two patients from whom the CAFs were derived. This may have resulted in differences in senescence due to aging and not to the carcinogenic process, and it is difficult to draw wider conclusions form only 2 CAF cultures. This will require to be taken into account when assessing the effects of senescence across a larger patient population.
This investigation confirms our earlier observation of the importance of IL-6/STAT signalling in the communication between cells in the OPSCC TME (19), an effect which is limited to HPV-negative tumour cells in culture. The role of the IL-6 pathway has been described in many cancers, linked to formation of an inflammatory TME, in addition to effects in the tumour cells themselves via the JAK/STAT signalling pathway (31). In HPV-negative OPSCC, IL-6 has been associated with poor prognosis, but this relationship has not been noted in HPV-positive OPSCC (32). We have previously demonstrated that the effects of IL-6 from fibroblasts may be, in part mediated via the production of HGF by HPV-negative OPSCC cells (19). Whereas other have associated this with nuclear localisation of PRMT5 or the expression of DEK expression (33). Similar findings have been demonstrated in cervical cancer, where IL-6/STAT3 signalling activates fibroblasts and increases senescence (in CAFs, but not normal fibroblasts) (34), increases in αSMA expression (35), and wider effects on other aspects of the TME include TH17 cells (which may contribute to immunosuppression in the TME (36).
Our investigations, using CAFs and a wider panel of cancer-associated cytokines, has identified osteopontin (OPN/SPP1) as a further mediator of the effects of CAF/OPSCC crosstalk, but again, only in HPV-negative cells (Figures 5, 6). The pattern of CCL2 production was not consistent in this system, and thus was not pursed further. In our co-culture investigation, we have demonstrated that the source of OPN in this system is the HPV-negative OPSCC cells and that OPN, in turn, acts on the fibroblasts to increase IL-6 production and increase contraction of collagen gels (Figures 7A,B). These effects can, in part, be abrogated using a CD44v6 inhibiting antibody (Figures 7C,D), demonstrating the OPN is only one of several mediators which may be acting in this manner (including HGF).
OPN is well recognised as a key mediator in the in TME of many malignant tumours, largely studied in the context of tumour associated macrophages (TAMs). Increased expression has been associated with reduced survival in a variety of tumours, with correlation with the extent of immune infiltration (37). Descriptive and mechanistic studies have also demonstrated a link with chemoresistance in ovarian (38), hepatocellular (39) and lung (40) malignancies. CAFs may interact with SPP1-expressing macrophages in the TME, and this feature has been associated with the EMT-like CAF phenotype (41). In colorectal carcinoma, a combination of FAP-expressing fibroblasts and OPN-expressing TAMs corelate with poor responses to immune checkpoint (42), and indeed, in poorly differentiated tumours, OPN in TAMs has been shown to induce senescence in tumour cells in high grade tumours, with the development of a profound SASP which may drive tumour progression (43).
In 2003, a paper was published identifying SPP1/OPN as a plasma prognostic marker in HNSCC, but few studies have followed up on the biology of this observation (44). SPP1 expression has subsequently been associated with poor outcomes in HNSCC (without subsite analysis) and with resistance to cetuximab (45, 46). It appears likely that the activity of OPN in HNSCC may be paracrine or autocrine in manner, and that this includes OPN-expressing macrophages, which have not been studied in this paper. SPP1-expressing TAM subpopulations have been shown to promote intravasation and metastasis in HNSCC (47) and low TAM containing tumours (CD68 CD163) have been associated with better survival (48).
Interestingly, given the lack of response between the CAFs and HPV-positive cells which we have again demonstrated, many more M1/M2 macrophages (which often express OPN) have been identified in HPV+ stroma, which, if at a high level, has been associated with poor regional control (49). It has also been demonstrated that macrophages expressing TREM1 are important in the progression of HPV+ OPSCC (50) and that fibroblasts with a matrix-CAF phenotype collaborate with SPP1-expressing TAMs to promote tumour progression in HNSCC (51). This may indicate a greater importance in the role of TAMs in the HPV-positive TME, which will require further investigation, as an additional element to the OPSCC-fibroblast model.
Conclusion
Whilst our investigations of the interactions between OPSCC and oropharynx fibroblasts have identified the role of OPN, these observations further serve to underline the complexity of intercellular communication in the OPSCC TME. We have demonstrated that OPN release from HPV-negative OPSCC cells was stimulated by IL-6 from OP CAFs. OPN resulted in contraction of OP CAFs and further release of IL-6. As in our previous investigations, the HPV-positive cells were much less responsive to fibroblast conditioned media in terms of their secretome and addressing the issues this raises regarding the role of the TME in HPV-positive tumours may only be possible using comparative single-cell sequencing of HPV positive and HPV negative tumours.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving humans were approved by NRES Committee (North of Scotland). The studies were conducted in accordance with the local legislation and institutional requirements. The Ethics Committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants’ legal guardians/next of kin because the tissues which were used in the TMAs were archive tissue, surplus to diagnostic requirement and were anonymized. The REC agreed for use of these tissues on that basis. Informed consent was obtained for the new CAF cultures as this was a new prospective collection.
Author contributions
NH: Formal Analysis, Funding acquisition, Investigation, Methodology, Validation, Writing – review & editing. HC: Resources, Validation, Writing – review & editing. HM: Resources, Writing – review & editing. RB: Conceptualization, Methodology, Supervision, Writing – review & editing. DL: Conceptualization, Methodology, Supervision, Writing – review & editing. KH: Conceptualization, Formal Analysis, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article.
NYH (first author) was funded by a PhD Scholarship from the University of Benghazi.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/froh.2024.1390081/full#supplementary-material
Supplementary Figure S1Demonstration of lack of CK6, HLA-DR and CD31 expression in cultures in NTFs and CAFs. (A) Cytokeratin 6 expression: CAF1 and CAF2 cells were collected, and total RNA extracted, and qRT-PCR was performed to amplify CK6 with β2m used for normalisation. NOK8 used as positive control and NTF6 as negative control. CAFs culture exhibited negligible expression of CK6 suggesting cultural purity. ***p < 0.000, using one-way ANOVA. Error bars = SD of (N = 3, n = 3). (B) HLA-DR expression: OPSCC CAFs clear of immune cell contamination. CAF1 and CAF2 were collected, and total RNA was extracted and quantified. qRT-PCR was performed to amplify the HLA-DR gene with β2m used for normalisation. MDM cells were used as positive control. CAFs culture exhibited a negligible expression of HLA-DR. ***p < 0.001, using one-way ANOVA. Error bars = SD of (N = 2, n = 3). (C) CD31 expression OPSCC CAFs cultures are clear of endothelial cell contamination. CAF1 and CAF2 were collected, and total RNA was extracted and quantified. qRT-PCR was performed to amplify the CD31 gene with β2m used for normalisation. HDMEC were used as positive control. CAFs culture exhibited a negligible expression of HDMEC. ***p < 0.001, using one-way ANOVA. Error bars = SD of (N = 2, n = 3).
Supplementary Figure S2Induction of senescence by H2O2 treatment in OPCAFs and NTF6. The three cultures were treated with 500mM H2O2 for 2h and maintained for 14 days to induce senescence. Quantification of the % of cells stained for SA-β-gal: data shows the mean proportion of cells stained blue in 3 random fields (magnification 20x). Confluent NTF6 were used as a positive control. *p < 0.05, **p < 0.01, ***p < 0.005. Error bars = SEM.
Supplementary Figure S3Baseline CAF1, CAF2 and NFT322 cytokine production. Array images show the developed cytokine membrane for CAF media without treatment. The array images are (A) CAF1 CM: Only CCL2 and MMP2 were detected. (B) CAF2 CM: MMP2, CCL2 and SPARC (weak) were detected. (C) NTF322 CM: MMP2 spots showed strong expression, other cytokines (SPARC, Serpin B5, DCN) showed weak signals. The cytokine array map is also included (D).
Supplementary Figure S4Cytokine array analysis of CAF conditioned media, collected after application of fresh media, after the treatment of the fibroblasts with OPSCC CM for 24h. The array images are (A) CAF1 stimulated by SCC89 CM (B) CAF1 stimulated by SCC2 CM, (C) CAF2 stimulated by SCC89 CM, (D) CAF2 stimulated by SCC2 CM, (E) NTF322 stimulated by SCC89 CM, (F) NTF322 stimulated by SCC2 CM. The number of cytokines identified is reduced when compared to the combined CM presented in Figure 4, but represents the cytokines produced by the fibroblasts alone. Of note, a greater range of cytokines is present in the media from cells which have been treated by HPV-negative OPSCC CM (A, C and E). Of note, osteopontin (SPP1) is not identified, suggesting that it is produced by the SCC cells.
Supplementary Figure S5Quantification of the proportion of senescent cells after rOPN treatment of NTFs. (A) Images representing SA-β-gal stain at basal level and after OPN treatment in NTF322 and NTF10, 10X magnification. (B) Quantification of SA-β-gal stain. The proportion of stained cells (blue precipitate) in 3 random fields at magnification 20x. Statistical analysis was performed using Student's t-test. Error bars = SD for (N = 3, n = 3).
References
1.
SchacheAGPowellNGCuschieriKSRobinsonMLearySMehannaHet alHPV-related oropharynx cancer in the United Kingdom: an evolution in the understanding of disease etiology. Cancer Res. (2016) 76:6598–606. 10.1158/0008-5472.CAN-16-0633
2.
LechnerMLiuJMastersonLFentonTR. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol. (2022) 19(5):306–27. 10.1038/s41571-022-00603-7
3.
AngKKHarrisJWheelerRWeberRRosenthalDINguyen-TânPFet alHuman papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. (2010) 363:24–35. 10.1056/NEJMoa0912217
4.
GillisonMLTrottiAMHarrisJEisbruchAHarariPMAdelsteinDJet alRadiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet. (2019) 393:40–50. 10.1016/S0140-6736(18)32779-X
5.
MehannaHRobinsonMHartleyAKongAForanBFulton-LieuwTet alRadiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet. (2019) 393:51–60. 10.1016/S0140-6736(18)32752-1
6.
GiraldoNASanchez-SalasRPeskeJDVanoYBechtEPetitprezFet alThe clinical role of the TME in solid cancer. Br J Cancer. (2019) 120:45–53. 10.1038/s41416-018-0327-z
7.
MarshDSuchakKMoutasimKAVallathSHopperCJerjesWet alStromal features are predictive of disease mortality in oral cancer patients. J Pathol. (2011) 223:470–81. 10.1002/path.2830
8.
AttiehYVignjevicDM. The hallmarks of CAFs in cancer invasion. Eur J Cell Biol. (2016) 95:493–502. 10.1016/j.ejcb.2016.07.004
9.
LeBleuVSKalluriR. A peek into cancer-associated fibroblasts: origins, functions and translational impact. Dis Model Mech. (2018) 11. 10.1242/dmm.029447
10.
ChenJYangPXiaoYZhangYLiuJXieDet alOverexpression of α-sma-positive fibroblasts (CAFs) in nasopharyngeal carcinoma predicts poor prognosis. J Cancer. (2017) 8:3897–902. 10.7150/jca.20324
11.
ZhanSLiuZZhangMGuoTQuanQHuangLet alOverexpression of B7-H3 in α-SMA-positive fibroblasts is associated with cancer progression and survival in gastric adenocarcinomas. Front Oncol. (2019) 9:1466. 10.3389/fonc.2019.01466
12.
CongXZhangYZhuZLiSYinXZhaiZet alCD66b+ neutrophils and α-SMA+ fibroblasts predict clinical outcomes and benefits from postoperative chemotherapy in gastric adenocarcinoma. Cancer Med. (2020) 9:2761–73. 10.1002/cam4.2939
13.
KnipperKDamanakisAIZhaoYBrunsCJSchmidtTPoppFCet alSpecific subtypes of carcinoma-associated fibroblasts are correlated with worse survival in resectable pancreatic ductal adenocarcinoma. Cancers (Basel). (2023) 15. 10.3390/cancers15072049
14.
YangYMaBHanLXuWDuXWeiWet alIntegrated single-cell and bulk RNA sequencing analyses reveal a prognostic signature of cancer-associated fibroblasts in head and neck squamous cell carcinoma. Front Genet. (2022) 13. 10.3389/fgene.2022.1028469
15.
MouTZhuHJiangYXuXCaiLZhongYet alHeterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma. Transl Oncol. (2023) 35:101717. 10.1016/j.tranon.2023.101717
16.
MelloneMHanleyCJThirdboroughSMellowsTGarciaEWooJet alInduction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis. Aging. (2016) 9:114–32. 10.18632/aging.101127
17.
LiuXLiuPChernockRDLang KuhsKALewisJSLiHet alImpact of human papillomavirus on the tumor microenvironment in oropharyngeal squamous cell carcinoma. Int J Cancer. (2022) 150:521–31. 10.1002/ijc.33849
18.
GiotakisAIRungeADudasJGlueckertRGottfriedTSchartingerVHet alAnalysis of cells of epithelial, connective tissue and immune differentiation in HPV-positive-, HPV-negative oropharyngeal carcinoma and normal oropharyngeal tissue by immunofluorescence multiplex image cytometry: a preliminary report. BMC Cancer. (2023) 23:1154. 10.1186/s12885-023-11440-x
19.
BoltRForanBMurdochCLambertDWThomasSHunterKD. HPV-negative, but not HPV-positive, oropharyngeal carcinomas induce fibroblasts to support tumour invasion through micro-environmental release of HGF and IL-6. Carcinogenesis. (2018) 39:170–9. 10.1093/carcin/bgx130
20.
ColleyHEHearndenVJonesAVWeinrebPHVioletteSMMacNeilSet alDevelopment of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma. Br J Cancer. (2011) 105:1582–92. 10.1038/bjc.2011.403
21.
MehannaHRapozoDvon ZeidlerSVHarringtonKJWinterSCHartleyAet alDeveloping and validating a multivariable prognostic-predictive classifier for treatment escalation of oropharyngeal squamous cell carcinoma: the PREDICTR-OPC study. Clin Cancer Res. (2024) 30:356–67. 10.1158/1078-0432.CCR-23-1013
22.
YimASmithCBrownAM. Osteopontin/secreted phosphoprotein-1 harnesses glial-, immune-, and neuronal cell ligand-receptor interactions to sense and regulate acute and chronic neuroinflammation. Immunol Rev. (2022) 311:224–33. 10.1111/imr.13081
23.
RahrotabanSMahdaviNAbdollahiAYazdaniFKaghazlooADerakhshanS. Carcinoma-associated fibroblasts are a common finding in the microenvironment of HPV-positive oropharyngeal squamous cell carcinoma. Appl Immunohistochem Mol Morphol. (2019) 27:683–8. 10.1097/PAI.0000000000000687
24.
HaaveHGulatiSBrekkeJLybakSVintermyrOKAarstadHJ. Tumor stromal desmoplasia and inflammatory response uniquely predict survival with and without stratification for HPV tumor infection in OPSCC patients. Acta Otolaryngol. (2018) 138:1035–42. 10.1080/00016489.2018.1497809
25.
KooleKClausenMJAMvan EsRJJvan KempenPMWMelchersLJKooleRet alFGFR family members protein expression as prognostic markers in oral cavity and oropharyngeal squamous cell carcinoma. Mol Diagn Ther. (2016) 20:363–74. 10.1007/s40291-016-0204-5
26.
NannapaneniSGriffithCCMaglioccaKRChenWLyuXChenZet alCo-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma. PLoS One. (2021) 16:e0247498. 10.1371/journal.pone.0247498
27.
KooleKvan KempenPMWvan BockelLWSmetsTvan der KloosterZDutmanACet alFGFR4 is a potential predictive biomarker in oral and oropharyngeal squamous cell carcinoma. Pathobiology. (2015) 82:280–9. 10.1159/000439536
28.
WattsTLCuiRSzaniszloPRestoVAPowellDWPinchukIV. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment. J Transl Med. (2016) 14:337. 10.1186/s12967-016-1091-6
29.
XiaoLZhuHShuJGongDZhengDGaoJ. Overexpression of TGF-β1 and SDF-1 in cervical cancer-associated fibroblasts promotes cell growth, invasion and migration. Arch Gynecol Obstet. (2022) 305:179–92. 10.1007/s00404-021-06137-0
30.
LiCGuoHZhaiPYanMLiuCWangXet alSpatial and single-cell transcriptomics reveal a cancer-associated fibroblast subset in HNSCC that restricts infiltration and antitumor activity of CD8+ T cells. Cancer Res. (2024) 84:258–75. 10.1158/0008-5472.CAN-23-1448
31.
HuangBLangXLiX. The role of IL-6/JAK2/STAT3 signaling pathway in cancers. Front Oncol. (2022) 12:1023177. 10.3389/fonc.2022.1023177
32.
LesinskiGBNannapaneniSGriffithCCPatelMChenWChenZet alInterleukin-6/STAT3 signaling is prominent and associated with reduced overall survival in p16 negative oropharyngeal squamous cell carcinoma. Head Neck Pathol. (2019) 13:304–12. 10.1007/s12105-018-0962-y
33.
KumarBYadavABrownNVZhaoSCipollaMJWakelyPEet alNuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status. Oncotarget. (2017) 8:14847–59. 10.18632/oncotarget.14682
34.
RenCChengXLuBYangG. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment. Eur J Cancer. (2013) 49:3889–99. 10.1016/j.ejca.2013.07.140
35.
ZhouBYuYYuLQueBQiuR. Sipi soup inhibits cancerassociated fibroblast activation and the inflammatory process by downregulating long noncoding RNA HIPK1AS. Mol Med Rep. (2018) 18:1361–8. 10.3892/mmr.2018.9144
36.
Walch-RückheimBStröderRTheobaldLPahne-ZeppenfeldJHegdeSKimY-Jet alCervical cancer-instructed stromal fibroblasts enhance IL23 expression in dendritic cells to support expansion of Th17 cells. Cancer Res. (2019) 79:1573–86. 10.1158/0008-5472.CAN-18-1913
37.
WeiTBiGBianYRuanSYuanGXieHet alThe significance of secreted phosphoprotein 1 in multiple human cancers. Front Mol Biosci. (2020) 7:565383. 10.3389/fmolb.2020.565383
38.
QianJLeSavageBLHubkaKMMaCNatarajanSEggoldJTet alCancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling. J Clin Invest. (2021) 131:e146186. 10.1172/JCI146186
39.
LiuGFanXTangMChenRWangHJiaRet alOsteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells. Cancer Lett. (2016) 383:171–82. 10.1016/j.canlet.2016.09.033
40.
MatsubaraEYanoHPanCKomoharaYFujiwaraYZhaoSet alThe significance of SPP1 in lung cancers and its impact as a marker for protumor tumor-associated macrophages. Cancers (Basel). (2023) 15. 10.3390/cancers15082250
41.
LuoHXiaXHuangL-BAnHCaoMKimGDet alPan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. Nat Commun. (2022) 13:6619. 10.1038/s41467-022-34395-2
42.
QiJSunHZhangYWangZXunZLiZet alSingle-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1 + macrophages in colorectal cancer. Nat Commun. (2022) 13:1742. 10.1038/s41467-022-29366-6
43.
YuSChenMXuLMaoESunS. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence. Front Immunol. (2023) 14:1175490. 10.3389/fimmu.2023.1175490
44.
LeQ-TSutphinPDRaychaudhuriSYuSCTTerrisDJLinHSet alIdentification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. Clin Cancer Res. (2003) 9:59–67. PMID: 12538452.
45.
LiuKHuHJiangHLiuCZhangHGongSet alUpregulation of secreted phosphoprotein 1 affects malignant progression, prognosis, and resistance to cetuximab via the KRAS/MEK pathway in head and neck cancer. Mol Carcinog. (2020) 59:1147–58. 10.1002/mc.23245
46.
BieTZhangX. Higher expression of SPP1 predicts poorer survival outcomes in head and neck cancer. J Immunol Res. (2021) 2021:8569575. 10.1155/2021/8569575
47.
WuJShenYZengGLiangYLiaoG. SPP1+ TAM subpopulations in tumor microenvironment promote intravasation and metastasis of head and neck squamous cell carcinoma. Cancer Gene Ther. (2023) 31(2):311–21. 10.1038/s41417-023-00704-0
48.
CioniBJordanovaESHooijbergEvan der LindenRde MenezesRXTanKet alHLA class II expression on tumor cells and low numbers of tumor-associated macrophages predict clinical outcome in oropharyngeal cancer. Head Neck. (2019) 41:463–78. 10.1002/hed.25442
49.
SnieturaMBrewczynskiAKopecARutkowskiT. Infiltrates of M2-like tumour-associated macrophages are adverse prognostic factor in patients with human papillomavirus-negative but not in human papillomavirus-positive oropharyngeal squamous cell carcinoma. Pathobiology. (2020) 87:75–86. 10.1159/000505522
50.
AzzimontiBRaimondoLSquarzantiDFRossoTZanettaPAluffi VallettiPet alMacrophages expressing TREM-1 are involved in the progression of HPV16-related oropharyngeal squamous cell carcinoma. Ann Med. (2021) 53:541–50. 10.1080/07853890.2021.1905872
51.
CaiZChenLChenSFangRChenXLeiW. Single-cell RNA sequencing reveals pro-invasive cancer-associated fibroblasts in hypopharyngeal squamous cell carcinoma. Cell Commun Signal. (2023) 21:292. 10.1186/s12964-023-01312-z
Summary
Keywords
oropharynx, squamous cell carcinoma, human papilloma virus, tumour microenvironment, osteopontin, SPP1, IL-6
Citation
Hendawi NY, Crane HL, Mehanna H, Bolt R, Lambert DW and Hunter KD (2024) Fibroblasts from HPV-negative oropharynx squamous cell carcinomas stimulate the release of osteopontin from cancer cells via the release of IL-6. Front. Oral. Health 5:1390081. doi: 10.3389/froh.2024.1390081
Received
22 February 2024
Accepted
26 April 2024
Published
13 May 2024
Volume
5 - 2024
Edited by
Linjun Joseph Shi, Shanghai Jiao Tong University, China
Reviewed by
Jozsef Dudas, Innsbruck Medical University, Austria
Fanglong Wu, Sichuan University, China
Updates
Copyright
© 2024 Hendawi, Crane, Mehanna, Bolt, Lambert and Hunter.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Keith D. Hunter Keith.hunter@liverpool.ac.uk
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.